January 15, 2026

In January 2026, Alverno Laboratories permanently referred Mycoplasma pneumoniae and Varicella-Zoster Virus antibody testing, as well as Apolipoprotein E (APOE) genotyping, to Quest Diagnostics with no changes to ordering codes, specimen requirements, or transport conditions; APOE specimen stability has been extended to 8 days refrigerated. Additionally, reporting for Antinuclear Antibody (ANA) by IFA testing was updated so that abnormal results for Soft codes ANARB and ANAIF are now flagged at titers ≥ 1:80 rather than the previous threshold of ≥ 1:40.